Found 35 matching trials
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide EARLY_PHASE1 The purpose of this study is to evaluate the effect of short-term treatment...
Show More Learn More & Join Trial
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer PHASE2 Researchers are seeking better ways to treat men who have non-metastatic ca...
Show More Learn More & Join Trial
Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer PHASE2 This trial aims to evaluate the efficacy and safety of neoadjuvant therapy ...
Show More Learn More & Join Trial
Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects PHASE1 A study to investigate absolute bioavailability of ODM-201 and to determine...
Show More Location
Quotient Clinical
Learn More & Join Trial
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) PHASE2 This is a multi-center, open-label, phase II, single-arm trial evaluating c...
Show More Location
Hospital São Rafael - Oncologia D'Or BA
Learn More & Join Trial
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer PHASE1 This is a Phase 1/2, open-label, randomized, dose finding and dose expansio...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases PHASE3 Prospective, multicenter, comparative, randomized placebo-controlled Phase ...
Show More Location
Pôle Santé Léonard de Vinci
Learn More & Join Trial
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer PHASE3 The purpose of the study is to assess the efficacy and safety of BAY1841788...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201) PHASE1 Evaluate the potential effect of hepatic or renal impairment on the pharmac...
Show More Location
Multiple Locations
Learn More & Join Trial
SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer PHASE2 This is a phase II, multicenter, randomized open-label and comparative tria...
Show More Status
Active Not Recruiting
Learn More & Join Trial